VentvilВентвил
A peptide mixture extracted from animal liver, studied in liver surgery research and a registered Phase II trial.
What the studies found
Lab research · 2023
Combined effect of polypeptide complexes on organotypic rat tissue cultures
Findings for this preparation
- Liver explant area index · Ventvil
- +21 ± 5% (n=17 explants)Versus medium alone. Ventvil in spleen gave −2 ± 1% (n=18, p > 0.05).p < 0.05 versus medium for liver in the results text.
- Liver explant area index · Ventvil + Thymalin
- +20 ± 3% (n=21 explants)Versus medium alone. Thymalin alone gave +6 ± 2% (n=20, p > 0.05).p < 0.05 versus medium for the combination.
- Spleen explant area index · Thymalin or Ventvil + Thymalin
- +23 ± 3% (n=21) and +22 ± 3% (n=19)Explants compared with medium alone.Both p < 0.05.
At 20 ng/mL, Ventvil increased the liver explant area index by 21 ± 5%. The spleen-explant change was nonsignificant.
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences
Study notes · methods, sources and limitations
Participants or model Three-month-old Wistar rats supplied explants. Methods report 280 liver, 300 spleen and 250 kidney explants. Donor rat count is unspecified.
Design Rat tissue explants were cultured for three days. Polypeptide complexes were tested at 20 ng/mL. Plain culture medium was the control.
Important limitations
- Explants are tissue fragments. Donor animal counts and handling of multiple explants from the same donor are unspecified. The article gives no direct statistical comparison of the combination against Ventvil alone. For Ventvil alone, the results text marks the liver result significant and the figure lacks a significance marker. The culture endpoint measures outgrowth.
- These are tissue-culture results. The reported liver-area changes with Ventvil alone and with Thymalin were similar. The report gives no head-to-head significance test for those two conditions.
Molecular Medicine. 2023;21(1):61–64. · Original journal article
Animal research · 2012
Injected Ventvil after partial liver removal in rats
- Liver-cell mitotic index · 32 h
- 2.316 with Ventvil vs 1.364 with saline after surgeryThe narrative reports p < 0.05 versus saline. The table marks significance against the preoperative measure only.
- Liver-cell mitotic index · 96 h
- 4.850 with Ventvil vs 2.012 with saline after surgeryAbout 2.4-fold in the reported groups. The patent prints a stricter p-value for the same means.The journal table marks p < 0.05 versus saline.
- Cells in S phase · 96 h
- No significant difference versus salineThe table shows 4.667 with Ventvil and 3.417 with saline.
At 96 hours the table lists a liver-cell mitotic index of 4.850 for treatment versus 2.012 for saline after surgery. The same values appear in an earlier patent that attributes them to injected synthetic EDL and reports a different animal count and dose.
More reported outcomes
- Total dividing cells · 96 h
- 9.513 with Ventvil vs 5.429 with saline after surgeryThe authors report a 75% difference.The table marks p < 0.05 versus saline.
Study notes · methods, sources and limitations
Participants or model 28 male rats assigned to four groups. Total enrollment is given without arm or time-point counts.
Design Random allocation to intact saline, surgery with saline, or surgery with one of two subcutaneous Ventvil doses. The published outcome table gives one set of Ventvil figures.
Important limitations
- The methods describe four groups. The table gives a single set of Ventvil figures, without showing dose-specific estimates or arm sizes. The entire numeric table repeats in patent RU2297239C1, Example 3. The journal describes 28 rats and calf-liver extract. The patent describes 18 rats and synthetic EDL. The sources leave the origin and attribution of the table unresolved. This was an animal surgery model. The paper measured cell division rather than functional recovery or clinical outcomes in people.
- The 2012 journal and 2007 EDL patent give identical means and uncertainty values across the table but describe different preparations and animal counts. The data cannot establish a preparation-specific effect or serve as independent replication.
Belgorod State University Scientific Bulletin, Medicine and Pharmacy. 2012;10(129), issue 18/1:37–40. · Original journal article
Lab research · 2015
[POLYPEPTIDES INFLUENCE ON TISSUE CELL CULTURES REGENERATION OF VARIOUS AGE RATS].
Findings for this preparation
Ventvil was among the calf-tissue preparations tested in corresponding rat organotypic cultures. The abstract reports tissue-growth and marker changes across the preparations; it does not provide a separate numerical effect estimate for this preparation.
Study notes · methods, sources and limitations
Participants or model Organotypic tissue cultures from young and old rats
Important limitations
- Tissue-culture growth is not organ regeneration in patients; equivalence to current branded products is unverified. Full methods, reporting completeness and independent replication remain to be appraised.
Advances in gerontology = Uspekhi gerontologii · PMID 26390619 · Original journal report
About Ventvil
Names in this research collection
Liver polypeptide complex
Research background
A liver-derived polypeptide complex discussed alongside Livagen (KEDA) in experimental hepatology. The extract and tetrapeptide are separate preparations.
Phase II sponsor and trial investigators ↗
- Compound class
- Tissue-derived polypeptide complex
- Research collection
- Peptide bioregulation · editorial grouping
- Institutions in linked studies
- St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
Phase I and Phase II placebo-controlled studies were registered. Results are unavailable in the linked records.
Study methods
Escalating-dose safety protocol, randomized liver disease protocol, a controlled rat surgery experiment and tissue-culture studies.
Independent replication
New citations are not automatically independent replication; shared programs and translated reports require cohort checks
Source access
Trial registrations and original experimental publications.
Safety evidence
Reported tolerability is not proof of safety; uncommon harms and long-term outcomes remain unresolved
Open a topic for the evidence assessment.
Findings by study
Animal research · 2012
Injected Ventvil after partial liver removal in rats
At 96 hours the table lists a liver-cell mitotic index of 4.850 for treatment versus 2.012 for saline after surgery. The same values appear in an earlier patent that attributes them to injected synthetic EDL and reports a different animal count and dose.
Liver-cell mitotic index · 32 h · 2.316 with Ventvil vs 1.364 with saline after surgery · The narrative reports p < 0.05 versus saline. The table marks significance against the preoperative measure only.
Study notes and original source
Injected Ventvil after partial liver removal in rats
Experimental calf-liver extract, peptide fractions up to 5 kDa, injected subcutaneously. · Original journal article
A. P. Ryzhak, B. I. Kuznik, G. A. Ryzhak · Belgorod State University Scientific Bulletin, Medicine and Pharmacy. 2012;10(129), issue 18/1:37–40.
At 96 hours the table lists a liver-cell mitotic index of 4.850 for treatment versus 2.012 for saline after surgery. The same values appear in an earlier patent that attributes them to injected synthetic EDL and reports a different animal count and dose.
Results and tables
Reported findings and study design
Random allocation to intact saline, surgery with saline, or surgery with one of two subcutaneous Ventvil doses. The published outcome table gives one set of Ventvil figures.
Population or model 28 male rats assigned to four groups. Total enrollment is given without arm or time-point counts.
Dose, route and schedule
Rats underwent removal of two-thirds of the liver and received saline or 0.01 or 0.1 mg Ventvil per rat subcutaneously at 2 and 24 hours after surgery. An intact group received saline. Liver histology was evaluated at 32 and 96 hours.
Protocol source ↗ · Russian journal PDF, pp. 37–40, methods and outcome table
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Liver-cell mitotic index · 32 h | 2.316 with Ventvil vs 1.364 with saline after surgery | The narrative reports p < 0.05 versus saline. The table marks significance against the preoperative measure only. |
| Liver-cell mitotic index · 96 h | 4.850 with Ventvil vs 2.012 with saline after surgery | About 2.4-fold in the reported groups. The patent prints a stricter p-value for the same means. · The journal table marks p < 0.05 versus saline. |
| Cells in S phase · 96 h | No significant difference versus saline | The table shows 4.667 with Ventvil and 3.417 with saline. |
| Total dividing cells · 96 h | 9.513 with Ventvil vs 5.429 with saline after surgery | The authors report a 75% difference. · The table marks p < 0.05 versus saline. |
The 2012 journal and 2007 EDL patent give identical means and uncertainty values across the table but describe different preparations and animal counts. The data cannot establish a preparation-specific effect or serve as independent replication.
Source for these results ↗ · Reviewed 2026-11-14
- Population / setting
- 28 male rats assigned to four groups. Total enrollment is given without arm or time-point counts.
- Source reviewed
- Russian journal PDF, pp. 37–40, methods and outcome table
Study limitations
- The methods describe four groups. The table gives a single set of Ventvil figures, without showing dose-specific estimates or arm sizes.
- The entire numeric table repeats in patent RU2297239C1, Example 3. The journal describes 28 rats and calf-liver extract. The patent describes 18 rats and synthetic EDL. The sources leave the origin and attribution of the table unresolved.
- This was an animal surgery model. The paper measured cell division rather than functional recovery or clinical outcomes in people.
Reviewed 2026-11-14.
Planned study · 2017
Ventvil Phase I injection safety trial registration (HEP-VTL-01)
The Phase I registration lists 52 healthy volunteers and describes a double-blind placebo-controlled study of injection safety and tolerability. Clinical results remain unavailable.
Study notes and original source
Ventvil Phase I injection safety trial registration (HEP-VTL-01)
Investigational intramuscular Ventvil liver polypeptide complex. · Clinical trial registration
SIA Peptides (sponsor) · Russian clinical-trial register mirror. Authorization No. 581, 3 November 2017
The Phase I registration lists 52 healthy volunteers and describes a double-blind placebo-controlled study of injection safety and tolerability. Clinical results remain unavailable.
- Population / setting
- 52 healthy volunteers listed in the registration. An analyzed sample and arm sizes are unavailable.
- Source reviewed
- Registry entry and contemporary sponsor announcement
Study limitations
- The public record lists the study as completed and supplies no group-level safety results or verified analyzed denominator.
Reviewed 2026-11-13.
Planned study · 2019
Ventvil Phase II placebo-controlled liver disease trial registration (VNT-08-2018)
The Phase II registry lists 130 planned participants in a randomized placebo-controlled comparison of injected Ventvil in alcohol-associated liver disease. Clinical results remain unavailable.
Study notes and original source
Ventvil Phase II placebo-controlled liver disease trial registration (VNT-08-2018)
Ventvil 5 mg lyophilizate for intramuscular injection, manufactured by Samson-Med. · Clinical trial registration
MedInvest (sponsor) · Russian clinical-trial register entry via ClinLine. Authorization No. 120, 13 March 2019
The Phase II registry lists 130 planned participants in a randomized placebo-controlled comparison of injected Ventvil in alcohol-associated liver disease. Clinical results remain unavailable.
- Population / setting
- 130 planned participants with alcohol-associated liver disease. Final enrollment and arm sizes are unavailable.
- Source reviewed
- Authorization No. 120, sponsor and contract research organization listings, investigator profiles and accessible Russian conference programs. Public sources provide registration details.
Study limitations
- The registry mirror lists the trial as completed in 2020. The registry mirror enumerates 11 organizations. ClinLine gives 12 in its header and lists 11 by name. Both give 130 planned participants. Enrollment, arm doses and schedules, clinical outcomes and adverse-event counts remain unavailable.
- 5 mg is the strength of the injectable vial. The registry record does not establish what each arm received.
Reviewed 2026-11-14.
Lab research · 2023
Combined effect of polypeptide complexes on organotypic rat tissue cultures
At 20 ng/mL, Ventvil increased the liver explant area index by 21 ± 5%. The spleen-explant change was nonsignificant.
Study notes and original source
Combined effect of polypeptide complexes on organotypic rat tissue cultures
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology · Pavlov Institute of Physiology, Russian Academy of Sciences
Organ-derived polypeptide preparations applied directly to rat tissue in culture. · Original journal article
N. I. Chalisova, G. A. Ryzhak, E. S. Egozova · Molecular Medicine. 2023;21(1):61–64.
At 20 ng/mL, Ventvil increased the liver explant area index by 21 ± 5% versus medium alone (17 explants). Ventvil plus Thymalin gave a 20 ± 3% increase (21 explants). Ventvil alone had no significant effect in spleen explants.
Results and tables
Reported findings and study design
Rat tissue explants were cultured for three days. Polypeptide complexes were tested at 20 ng/mL. Plain culture medium was the control.
Population or model Three-month-old Wistar rats supplied explants. Methods report 280 liver, 300 spleen and 250 kidney explants. Donor rat count is unspecified.
Dose, route and schedule
Rat tissue fragments were incubated for three days at 37 °C in 3 mL of medium, with test extracts at a reported concentration of 20 ng/mL or medium alone. The area index compares total explant area with the central tissue area.
Protocol source ↗ · Russian full article, pp. 61–64, methods and results. Sample sizes refer to tissue explants.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Liver explant area index · Ventvil | +21 ± 5% (n=17 explants) | Versus medium alone. Ventvil in spleen gave −2 ± 1% (n=18, p > 0.05). · p < 0.05 versus medium for liver in the results text. |
| Liver explant area index · Ventvil + Thymalin | +20 ± 3% (n=21 explants) | Versus medium alone. Thymalin alone gave +6 ± 2% (n=20, p > 0.05). · p < 0.05 versus medium for the combination. |
| Spleen explant area index · Thymalin or Ventvil + Thymalin | +23 ± 3% (n=21) and +22 ± 3% (n=19) | Explants compared with medium alone. · Both p < 0.05. |
| Kidney explant area index · Nephropept or Nephropept + Thymalin | +27 ± 5% (n=22) and +20 ± 1% (n=17) | Explants compared with medium alone. Nephropept in spleen gave −12 ± 1% (n=19, p > 0.05). · Both kidney results p < 0.05 versus medium. |
| Brain cortex explant area index · Cortexin + Thymalin | +25 ± 1% (n=21 explants) | Versus medium alone. The paper gives no Cortexin-only value in this comparison. · p < 0.05. |
| Spleen explant area index · Thymalin combinations | +23 ± 1% with Nephropept (n=19), +24 ± 3% with Cortexin (n=20) | Explants compared with medium alone. · Both p < 0.05. |
These are tissue-culture results. The reported liver-area changes with Ventvil alone and with Thymalin were similar. The report gives no head-to-head significance test for those two conditions.
Source for these results ↗ · Reviewed 2026-11-14
- Population / setting
- Three-month-old Wistar rats supplied explants. Methods report 280 liver, 300 spleen and 250 kidney explants. Donor rat count is unspecified.
- Source reviewed
- Russian full article, pp. 61–64, methods and results. Sample sizes refer to tissue explants.
Study limitations
- Explants are tissue fragments. Donor animal counts and handling of multiple explants from the same donor are unspecified.
- The article gives no direct statistical comparison of the combination against Ventvil alone. For Ventvil alone, the results text marks the liver result significant and the figure lacks a significance marker. The culture endpoint measures outgrowth.
Reviewed 2026-11-14.
Lab research · 2015
[POLYPEPTIDES INFLUENCE ON TISSUE CELL CULTURES REGENERATION OF VARIOUS AGE RATS].
Ventvil was among the calf-tissue preparations tested in corresponding rat organotypic cultures. The abstract reports tissue-growth and marker changes across the preparations; it does not provide a separate numerical effect estimate for this preparation.
Study notes and original source
[POLYPEPTIDES INFLUENCE ON TISSUE CELL CULTURES REGENERATION OF VARIOUS AGE RATS].
· Original journal report
Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN · Advances in gerontology = Uspekhi gerontologii · PMID 26390619
Calf-tissue preparations, including Ventvil, stimulated corresponding tissue-culture growth with changes in proliferation-related markers.
- Population / setting
- Organotypic tissue cultures from young and old rats
- Source reviewed
- Primary citation and indexed abstract reviewed through Europe PMC. Full article not appraised.
Study limitations
- Tissue-culture growth is not organ regeneration in patients; equivalence to current branded products is unverified.
- Full methods, reporting completeness and independent replication remain to be appraised.
Reviewed 2026-10-05.
Review of earlier studies · 2020
The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology
Reviews liver polypeptide complex Ventvil and KEDA/Livagen in experimental fibrosis and hepatitis, with immune and antioxidant outcomes.
Study notes and original source
The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology
Author affiliations · St. Petersburg Institute of Bioregulation and Gerontology
Kuznik BI, Khasanova NB, Ryzhak GA, Mezsheriakova IE, Khavinson VK · Adv Gerontol 33(1):159-164. PMID 32362099
Reviews liver polypeptide complex Ventvil and KEDA/Livagen in experimental fibrosis and hepatitis, with immune and antioxidant outcomes.
- Population / setting
- Animal and in-vitro liver pathology models
- Source reviewed
- Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Study limitations
- Extract and tetrapeptide are separate interventions.
- This is a review of experimental models, not a clinical hepatitis treatment trial.
Reviewed 2026-09-29.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗